Am J Epidemiol 2004; 159:269-276.
Copyright © 2004 by the Johns
Hopkins Bloomberg School of Public Health
ORIGINAL CONTRIBUTIONS |
Androgen Receptor Gene Polymorphisms and Increased Risk of Urologic Measures of Benign Prostatic Hyperplasia
1 Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, MN.
2 Department of Health Sciences Research, Division of Biostatistics, Mayo Clinic, Rochester, MN.
3 Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
4 Department of Urology, Mayo Clinic, Rochester, MN.
The association between androgen receptor gene polymorphisms and benign prostatic hyperplasia was investigated among 510 men randomly selected from Olmsted County, Minnesota. From 1990 through 2000, lower urinary tract symptom severity was assessed by the American Urological Association Symptom Index (AUASI), and peak urinary flow rate, prostate volume, and serum prostate-specific antigen level were measured. Androgen receptor CAG and GGN genotyping was performed. A CAG repeat length of <21 was associated with an enlarged prostate (hazard ratio (HR) = 1.4, 95% confidence interval (CI): 1.0, 1.9) and a serum prostate-specific antigen level >1.4 ng/ml (HR = 1.5, 95% CI: 1.1, 2.0). A GGN repeat length of <16 was associated with an AUASI >7 (HR = 1.6, 95% CI: 1.1, 2.3) and a serum prostate-specific antigen level >1.4 ng/ml (HR = 1.5, 95% CI: 1.0, 2.3). Having <21 CAG repeats and <16 GGN repeats compared with having neither was associated with an enlarged prostate (HR = 2.5, 95% CI: 1.5, 4.2), a serum prostate-specific antigen level >1.4 ng/ml (HR = 2.8, 95% CI: 1.6, 4.7), a peak flow rate <12 ml/second (HR = 1.9, 95% CI: 1.1, 3.4), and an AUASI >7 (HR = 1.6, 95% CI: 1.0, 2.7). Androgen receptor gene polymorphisms may have a potential role in the pathogenesis of benign prostatic hyperplasia.
cohort studies; polymorphism (genetics); prostate; prostatic hyperplasia; receptors, androgen; risk factors; signs and symptoms; urinary retention
Abbreviations: Abbreviations: AUASI, American Urological Association Symptom Index; BPH, benign prostatic hyperplasia; CI, confidence interval; HR, hazard ratio; PSA, prostate-specific antigen.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. J. Freedland, W. B. Isaacs, E. A. Platz, M. K. Terris, W. J. Aronson, C. L. Amling, J. C. Presti Jr, and C. J. Kane Prostate Size and Risk of High-Grade, Advanced Prostate Cancer and Biochemical Progression After Radical Prostatectomy: A Search Database Study J. Clin. Oncol., October 20, 2005; 23(30): 7546 - 7554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Buchanan, M. Yang, A. Cheong, J. M. Harris, R. A. Irvine, P. F. Lambert, N. L. Moore, M. Raynor, P. J. Neufing, G. A. Coetzee, et al. Structural and functional consequences of glutamine tract variation in the androgen receptor Hum. Mol. Genet., August 15, 2004; 13(16): 1677 - 1692. [Abstract] [Full Text] [PDF]
|
|